SPARC and colorectal carcinoma: These data confirmed that SPARC functioned as a oncogene and hsa-miR-29c-3p as a tumor suppressor gene, and suggested that hsa-miR-29c-3p might influence the downstream pathways by targeting SPARC to affect CRC cell functions.